Durect Corp

* Says prescription drug user fee act (PDUFA) date forremoxy NDA of September 25, 2016 is unchanged

* An FDA advisory committee meeting for remoxy is not neededand no change to September 25, 2016 PDUFA date

* Pain Therapeutics stated that FDA advised them thatregulatory review of remoxy new drug application (NDA) remainsactive and on-going

* Durect provides remoxy updateSource text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)



http://feeds.reuters.com/~r/reuters/...E/idUSASC08VWS